Enhance MD vs IVIM Health: Price, Protocols, Ratings Compared
Quick answer: Enhance MD vs IVIM Health — Enhance MD focuses on low introductory pricing and flat-rate dosing (semaglutide from $49 first month; tirzepatide from $99 first month), while IVIM Health emphasizes clinician-guided protocols, dual 4.9-star third-party ratings, and a free-month-membership code (GIFT75). Early verdict: choose Enhance MD if entry cost and flat-rate titration matter; choose IVIM Health if third-party ratings and a structured GLP-1 ID program are top priorities.
Start with Enhance MD pricing details
Top differences at a glance for Enhance MD vs IVIM Health
| Criteria | Enhance MD | IVIM Health |
|---|---|---|
| Introductory price | Semaglutide from $49 first month; tirzepatide from $99 first month | Starts at $75 listed; site notes first-month offers and code GIFT75 for a free month membership |
| Ongoing pricing model | Flat-rate pricing: same price at every dose after intro; no escalation during titration | Ongoing pricing cited around $174/month after initial month; program fee may apply |
| Program approach | Clinician-directed compounding platform emphasizing affordable multi-compound access | Proprietary GLP-1 ID protocol with clinician-guided titration and optimization claims |
| Third-party validation | 10,000+ patients treated (provider-reported) | 4.9-star ratings on both Google and Trustpilot (provider-reported) |
| Regulatory note | Compounded medications; not FDA-approved and not reviewed by FDA for safety, effectiveness, or quality | Compounded medications; not FDA-approved and not reviewed by FDA for safety, effectiveness, or quality |
Pricing and billing: entry cost versus ongoing structure
Enhance MD vs IVIM Health diverge most clearly on how pricing is presented. Enhance MD advertises semaglutide from $49 first month and tirzepatide from $99 first month and highlights flat-rate pricing that “stays the same at every dose, no fee escalation.” IVIM Health markets a promotional route to lower upfront cost via code GIFT75 for a free-month membership and notes semaglutide at $75/mo and tirzepatide at $133/mo with an additional program fee. The sources preserve that IVIM’s ongoing rate moves to about $174/month after initial pricing, while Enhance MD emphasizes predictable flat-rate billing once the ongoing rate is set.
See IVIM Health membership and GIFT75
What that means for patients
If your priority is the lowest possible first-month outlay and no dose-based price increases, the source material supports Enhance MD’s positioning. If you prefer a program that reduces upfront commitment via a free-month code and includes a no-obligation consultation, IVIM Health documents a free consultation value and the GIFT75 free-month-membership offer.
Programs, protocols, and clinical claims
Enhance MD presents a clinician-directed metabolic program offering both semaglutide and tirzepatide on one platform and highlights wide patient volume. IVIM Health promotes a proprietary GLP-1 ID protocol and cites studies and internal published data suggesting accelerated outcomes, including a provider claim of “lose weight 40% faster” and retrospective observational publications that support its outcomes messaging. IVIM’s claim is noted in the source as a proprietary protocol claim and not a head-to-head randomized controlled trial.
Explore Enhance MD treatment options
Trust signals and patient experience
Both providers report trust markers but in different forms. Enhance MD reports more than 10,000 patients treated as its evidence of experience. IVIM Health reports dual 4.9-star ratings on Google and Trustpilot and references peer-reviewed retrospective observational studies in Obesity Pillars supporting their outcome discussions. The IVIM source explicitly frames the studies as not randomized head-to-head trials and cautions that results may vary.
Medication options and regulatory cautions
Both sources state they prescribe compounded semaglutide and tirzepatide and include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Enhance MD emphasizes having both semaglutide and tirzepatide available on one platform and low first-month pricing for both. IVIM notes compounded formulations, program fees, and state availability limits in its materials.
Final comparison and recommendation
Enhance MD vs IVIM Health: use the primary keyword to summarize differences — Enhance MD is the lower-cost entry option with flat-rate dosing and multi-compound availability; IVIM Health is the structured, clinically branded program with strong third-party ratings and promotional offers that lower upfront commitment.
Choose Enhance MD if you need the lowest disclosed first-month price on semaglutide or tirzepatide and a flat-rate billing approach that avoids dose-based escalation. Choose IVIM Health if third-party ratings, a proprietary clinician-guided GLP-1 ID protocol, and a free-month or no-obligation consultation matter more to your decision.